Skip to content
DataLookout
Menu

Jeeyun Lee clinical trial pipeline

Get alerts when Jeeyun Lee's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-21

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  1. Notable: Trastuzumab Deruxtecan(T-DXd) and Afatinib Combination in HER2-low Advanced Gastric Cancer Primary completion pushed from Dec 2025 to Dec 1, 2027 Jeeyun LeePhase 1/2 NCT06085755
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

Active trials by phase

Phase 1/2
1
Phase 2
2

Disease areas by active trials

Get alerts when Jeeyun Lee's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free